Study of heart artery plaque in people with type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial looks at coronary (heart) artery plaque using CT scans (CCTA) in people with type 2 diabetes who do not have symptoms. It may help doctors understand who is at risk of heart problems and how plaque changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 19 or older
- Have type 2 diabetes and no chest symptoms (asymptomatic)
- Have already had an initial heart CT scan (CCTA) at Asan Medical Center’s Diabetes Center between Feb 2008 and Jun 2012
- You must be able to give written consent and return for follow-up CT scans
- Your kidney function blood test (creatinine) must be 1.5 mg/dL or lower
- You cannot be pregnant, and you must not have had a severe allergic reaction to CT contrast dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a follow-up CT scan of your heart arteries to see how diabetes-related plaque buildup changes over time. It may help researchers understand how well current diabetes treatments are protecting your heart.
This trial uses a low-dose CT scan of the heart’s arteries to measure coronary artery calcification in people with type 2 diabetes. It aims to better understand heart calcium buildup and may help improve risk assessment for people with diabetes.
This study uses a special camera (OCT and NIRS) inside heart arteries to look for dangerous plaque in people with diabetes. It may help doctors decide the best treatment to prevent heart attacks.
This study uses a special CT scan to look at your heart more closely. It may help people with known or suspected heart problems or type 2 diabetes.
This study looks for early, “silent” changes in heart function in adults with type 2 diabetes, even if you feel okay. It uses heart scans and looks for factors that may help explain why these changes happen.
This study tests whether a diabetes medication called SGLT2 inhibitors can slow the buildup of plaque in heart arteries. Researchers will use special CT scans to track changes in your coronary arteries over time.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.